Action TIL INSTIL BIO, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Instil Bio, Inc.

Actions

TIL

US45783C2008

Marché Fermé - Nasdaq
Autres places de cotation
 22:30:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
10,6 USD +1,92% Graphique intraday de Instil Bio, Inc. -0,38% +39,11%
26/04 Instil Bio, Inc. annonce des changements au sein de son conseil d'administration CI
12/04 INSTIL BIO, INC. : Jefferies & Co. n'est plus acheteur ZM

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Instil Bio, Inc. Announces Board Changes
North American Morning Briefing : Stock Futures -2-
Instil Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Instil Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Instil Bio Announces Strategic Update
Instil Bio, Inc. Enters into Agreement with A Collaboration to Conduct Preclinical Manufacturing Feasibility Studies in the ITIL-306 Program
Instil Bio, Inc. Announces the Closure of Its UK Manufacturing and Clinical Operations
Instil Bio, Inc.(NasdaqCM:TIL) dropped from NASDAQ Biotechnology Index
Instil Bio Says 1-for-20 Reverse Stock Split to Take Effect on Dec. 7
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
Instil Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting
Instil Bio, Inc.(NasdaqCM:TIL) dropped from S&P Global BMI Index
Instil Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
Instil Bio, Inc. Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
Instil Bio, Inc.(NasdaqGS:TIL) dropped from Russell Small Cap Comp Value Index
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action TIL
  4. Actualités Instil Bio, Inc.
  5. Autres langues